Pharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Identify first generic entrants

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Hydroxyprogesterone caproate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for hydroxyprogesterone caproate?

Hydroxyprogesterone caproate is the generic ingredient in four branded drugs marketed by Akorn, Bristol Myers Squibb, Allergan Sales Llc, Amag Pharma Usa, and Aspen Global Inc, and is included in six NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for hydroxyprogesterone caproate. Three suppliers are listed for this compound.

Summary for Generic Name: hydroxyprogesterone caproate

Drug Master File Entries: see list10
Suppliers / Packagers: see list3
Bulk Api Vendors: see list44
Clinical Trials: see list18
Patent Applications: see list4,460
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:hydroxyprogesterone caproate at DailyMed

Pharmacology for Ingredient: hydroxyprogesterone caproate

Ingredient-typeProgesterone Congeners
Drug ClassProgestin
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb
hydroxyprogesterone caproate
INJECTABLE;INJECTION016911-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
Allergan Sales Llc
hydroxyprogesterone caproate
INJECTABLE;INJECTION017439-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Amag Pharma Usa
hydroxyprogesterone caproate
SOLUTION;INTRAMUSCULAR021945-002Feb 19, 2016RXYesYes► Subscribe► Subscribe
Aspen Global Inc
hydroxyprogesterone caproate
INJECTABLE;INJECTION200271-001Aug 24, 2015RXNoYes► Subscribe► Subscribe
hydroxyprogesterone caproate
INJECTABLE;INJECTION018004-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.